Get started
Cybin Inc.Cybin Inc.Cybin Inc.

Cybin Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

CYBN chart


Full chart

CYBN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪168.15 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.90 USD
Net income (FY)
‪−78.61 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪20.39 M‬
Beta (1Y)
—

About CYBIN INC.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Douglas L. Drysdale
Website
cybin.com
Headquarters
Toronto
Founded
2016
FIGI
BBG00MFNRRT4
Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Check out other big names from the same industry as CYBN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CYBN news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CYBN is 7.46 USD — it has increased by 5.34% in the past 24 hours. Watch Cybin Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Cybin Inc. stocks are traded under the ticker CYBN.
CYBN stock has fallen by −0.90% compared to the previous week, the month change is a −13.79% fall, over the last year Cybin Inc. has showed a −29.81% decrease.
We've gathered analysts' opinions on Cybin Inc. future price: according to them, CYBN price has a max estimate of 150.25 USD and a min estimate of 25.04 USD. Watch CYBN chart and read a more detailed Cybin Inc. stock forecast: see what analysts think of Cybin Inc. and suggest that you do with its stocks.
CYBN reached its all-time high on Aug 2, 2021 with the price of 128.44 USD, and its all-time low was 1.08 USD and was reached on May 22, 2020. View more price dynamics on CYBN chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Cybin Inc. financials in yearly and quarterly reports right on TradingView.
Cybin Inc. is going to release the next earnings report on Aug 7, 2025. Keep track of upcoming events with our Earnings Calendar.
CYBN earnings for the last quarter are −1.01 USD per share, whereas the estimation was −0.85 USD resulting in a −18.70% surprise. The estimated earnings for the next quarter are −0.96 USD per share. See more details about Cybin Inc. earnings.
Cybin Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
CYBN net income for the last quarter is ‪−21.25 M‬ USD, while the quarter before that showed ‪−7.33 M‬ USD of net income which accounts for −190.04% change. Track more Cybin Inc. financial stats to get the full picture.
No, CYBN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CYBN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cybin Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cybin Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cybin Inc. stock shows the sell signal. See more of Cybin Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.